Salari Farhad, Fakhraie Ghasem, Asadi Amoli Fahimeh, Zarei-Ghanavati Mehran
Department of Cornea, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
J Curr Ophthalmol. 2022 Apr 16;34(1):115-117. doi: 10.4103/JOCO.JOCO_159_21. eCollection 2022 Jan-Mar.
To report a case of intracameral injection of methotrexate (MTX) to treat the epithelial ingrowth that occurred following glaucoma surgery.
A case report of a 40-year-old male with epithelial ingrowth after implantation of Ahmed glaucoma valve.
The patient was treated with 11 doses of weekly intracameral MTX (400 mg/0.1 ml). Clinical evidence of recurrence was not observed after 11 months of follow-up.
Intracameral MTX can be used as an alternative for the treatment of epithelial ingrowth.
报告1例前房内注射甲氨蝶呤(MTX)治疗青光眼手术后发生的上皮植入的病例。
1例40岁男性患者植入艾哈迈德青光眼引流阀后发生上皮植入的病例报告。
患者接受了11次每周1次的前房内MTX注射(400mg/0.1ml)。随访11个月后未观察到复发的临床证据。
前房内MTX可作为治疗上皮植入的一种替代方法。